BindingDB logo
myBDB logout

BDBM50409325 CHEMBL437069

SMILES: CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O

InChI Key: InChIKey=KHEAOXMYFAQTDU-JTZFLWRISA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50409325   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
HLA class I histocompatibility antigen A-3


(Homo sapiens (Human))
BDBM50409325
PNG
(CHEMBL437069)
Show SMILES CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O
Show InChI InChI=1S/C42H67N9O14/c1-20(2)15-26(44-31(56)17-43)35(57)45-27(16-24-10-12-25(55)13-11-24)36(58)46-28(18-52)37(59)47-29(19-53)38(60)50-34(23(7)54)40(62)48-32(21(3)4)41(63)51-14-8-9-30(51)39(61)49-33(22(5)6)42(64)65/h10-13,20-23,26-30,32-34,52-55H,8-9,14-19,43H2,1-7H3,(H,44,56)(H,45,57)(H,46,58)(H,47,59)(H,48,62)(H,49,61)(H,50,60)(H,64,65)/t23-,26+,27+,28+,29+,30+,32+,33+,34+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 20n/an/an/an/an/an/a



Edward Jenner Institute for Vaccine Research

Curated by ChEMBL


Assay Description
MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)


J Med Chem 44: 3572-81 (2001)


BindingDB Entry DOI: 10.7270/Q23B61B5
More data for this
Ligand-Target Pair
HLA class I histocompatibility antigen A-3


(Homo sapiens (Human))
BDBM50409325
PNG
(CHEMBL437069)
Show SMILES CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O
Show InChI InChI=1S/C42H67N9O14/c1-20(2)15-26(44-31(56)17-43)35(57)45-27(16-24-10-12-25(55)13-11-24)36(58)46-28(18-52)37(59)47-29(19-53)38(60)50-34(23(7)54)40(62)48-32(21(3)4)41(63)51-14-8-9-30(51)39(61)49-33(22(5)6)42(64)65/h10-13,20-23,26-30,32-34,52-55H,8-9,14-19,43H2,1-7H3,(H,44,56)(H,45,57)(H,46,58)(H,47,59)(H,48,62)(H,49,61)(H,50,60)(H,64,65)/t23-,26+,27+,28+,29+,30+,32+,33+,34+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 33.0n/an/an/an/an/an/a



Edward Jenner Institute for Vaccine Research

Curated by ChEMBL


Assay Description
MHC class I HLA-A*0201 binding affinity assayed by based inhibition of binding of a radiolabeled standard peptide (FLPSDYFPSV)


J Med Chem 44: 3572-81 (2001)


BindingDB Entry DOI: 10.7270/Q23B61B5
More data for this
Ligand-Target Pair